LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Strona główna・Stock List・Nektar Therapeutics

Nektar Therapeutics

Closed

73.77 0.19

Buy Sell

Overview

Share price change

24h

Current

Min

71.56

Max

73.83

Key metrics
By Trading Economics
Income	6.1M -36M
Sales	615K 12M
EPS	-1.87
Profit margin	-301.289
Employees	61
EBITDA	6.9M -29M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+68.67% upside

Dividends
By Dow Jones
Next Earnings	11 mar 2026

Market Stats
By TradingEconomics
Market Cap	856M 2B
Previous open	73.58
Previous close	73.77

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 lut 2026, 17:37 UTC

Acquisitions, Mergers, Takeovers

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

20 lut 2026, 16:18 UTC

Major Market Movers

Footwear Stocks Rise After Supreme Court Strikes Down Tariffs

20 lut 2026, 23:12 UTC

Acquisitions, Mergers, Takeovers

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 lut 2026, 22:12 UTC

Earnings

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 lut 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20 lut 2026, 21:23 UTC

Earnings

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 lut 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 lut 2026, 21:01 UTC

Acquisitions, Mergers, Takeovers

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 lut 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

20 lut 2026, 20:17 UTC

Market Talk

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

20 lut 2026, 20:11 UTC

Market Talk

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

20 lut 2026, 19:59 UTC

Market Talk

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

20 lut 2026, 19:58 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

20 lut 2026, 19:49 UTC

Market Talk

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

20 lut 2026, 19:09 UTC

Market Talk

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

20 lut 2026, 19:00 UTC

Market Talk

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

20 lut 2026, 18:28 UTC

Market Talk

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

20 lut 2026, 18:20 UTC

Market Talk

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

20 lut 2026, 18:05 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20 lut 2026, 18:04 UTC

Market Talk

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

20 lut 2026, 17:38 UTC

Market Talk

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

20 lut 2026, 17:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 lut 2026, 17:24 UTC

Market Talk

Correction to Treasury Yields Fall Market Talk

20 lut 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

20 lut 2026, 16:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20 lut 2026, 16:53 UTC

Market Talk

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

20 lut 2026, 16:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 lut 2026, 16:45 UTC

Market Talk

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

20 lut 2026, 16:40 UTC

Market Talk

Trade Threats Facing Canada Not Removed by Supreme Court's Ruling -- Market Talk

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

68.67% upside

12 Months Forecast

Average 123.43 USD 68.67%

High 165 USD

Low 102 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

Other stocks from the sector

LLY

Eli Lilly and Co.

1,008.73

↓-1.37%

JNJ

Johnson and Johnson

242.5

↓-1.77%

ABBV

AbbVie Inc

224.75

↑ +0.24%

NVS

Novartis AG

162.69

↓-0.47%

MRK

Merck & Co Inc.

122.26

↑ +0.39%

Nektar Therapeutics

Overview

Share price change

Key metrics

Recommendations

Dividends

Market Stats

Technical Score

Nektar Therapeutics Chart

Related News

Peer Comparison

Nektar Therapeutics Forecast

Price Target

Rating Consensus

Technical Score

Financials

Other stocks from the sector